Rocket Lab is the second largest US satellite launch provider, poised for significant growth with its upcoming Neutron rocket, expected to start commercial operations next year. The success and timely launch of Neutron are critical, as delays could increase dilution risk due to the equity component of Rocket Lab's recent acquisition of Iridium and refinancing needs. The Iridium acquisition transforms Rocket Lab into a fully integrated space company with global coverage and immediate profitability benefits. Despite current stock weakness presenting a buying opportunity, the key risk remains the execution of the Neutron rocket, which will impact both valuation and dilution.
The satellite industry is shifting focus from rockets to controlling radio spectrum for direct-to-handset connectivity. The FCC's new Supplemental Coverage from Space authorization enables satellites to beam service directly to ordinary smartphones. ...
Rocket Lab reported $234 million in revenue for Q2, with a backlog rising to $2.36 billion, driven by its Space Systems segment which accounted for 81% of revenue. The company aims to price its Neutron rocket between $50 million and $55 million witho...
ARK Invest, led by Cathie Wood, purchased 705,102 shares of Rocket Lab during a recent stock decline, viewing the dip as a buying opportunity. Rocket Lab, valued at around $38 billion, is a smaller public rival to SpaceX, focusing on small-satellite ...
SpaceX's stock currently trades below its first closing price despite a strong IPO debut, with a consensus analyst target price about 48% higher than the current price. Raymond James analyst Brian Gesuale projects a much more optimistic outlook, sett...
Rocket Lab is recognized for its strong execution in the aerospace sector, consistently beating analyst estimates for eight quarters. However, its stock trades at a high forward Price to Sales ratio of 40x, a significant premium over the sector media...
